Protagonist Therapeutics
PTGX
Reported
Friday, February 21
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 1.03 | 1.98 | 0.95 | 92.23% |
| Revenue | 53.5M | 171M | 117M | 218.83% |
WhatIF - Earnings
EPS Beat Expectations by $0.95
Protagonist Therapeutics (PTGX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything